Get the Stockscreener App
11.82
1.37%
0.16
Abrdn Life Sciences Investors stock is traded at $11.82, with a volume of 61,175.
It is up +1.37% in the last 24 hours and down -10.32% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$11.66
Open:
$11.75
24h Volume:
61,175
Relative Volume:
0.47
Market Cap:
$331.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.10%
1M Performance:
-10.32%
6M Performance:
-22.19%
1Y Performance:
-7.58%
1-Day Range:
$11.72
$11.83
1-Week Range:
$11.14
$11.93
52-Week Range:
$10.55
$15.90
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
11.82 | 331.69M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.46 | 3.47B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
31.57 | 2.74B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
24.84 | 2.34B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
18.18 | 2.17B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
13.15 | 2.12B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $179,718.00 in Stock - MarketBeat
Saba Capital Management, L.P. Sells 30,156 Shares of Abrdn Life Sciences Investors (NYSE:HQL) Stock - MarketBeat
1607 Capital Partners LLC Sells 102,354 Shares of Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Declines By 26.0% - Defense World
Series CGlycomine - Crunchbase
LPL Financial LLC Has $3.77 Million Holdings in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock - Investing.com Australia
Saba capital management sells $179,718 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
Saba capital management sells $179,718 in Abrdn life sciences stock - Investing.com
LPL Financial LLC Raises Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock By Investing.com - Investing.com South Africa
Abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year LowTime to Sell? - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 6,889 Shares - MarketBeat
Landscape Capital Management L.L.C. Makes New $573,000 Investment in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
LPL Financial LLC Buys 129,313 Shares of Abrdn Life Sciences Investors (NYSE:HQL) - Defense World
LPL Financial LLC Grows Stock Holdings in Abrdn Healthcare Investors (NYSE:HQH) - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 29,102 Shares - MarketBeat
Saba capital management sells abrdn life sciences investors stock for $205,931 By Investing.com - Investing.com
Commonwealth Equity Services LLC Purchases 933 Shares of Abrdn Life Sciences Investors (NYSE:HQL) - Defense World
Abrdn Healthcare Investors (NYSE:HQH) Hits New 12-Month LowShould You Sell? - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $611,677.34 in Stock - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $428,315.22 in Stock - MarketBeat
Abrdn Life Sciences investors sees $576,754 in stock sales by Saba Capital By Investing.com - Investing.com UK
Prevail Innovative Wealth Advisors LLC Makes New $590,000 Investment in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Decreases By 37.4% - MarketBeat
Saba capital management sells $611,677 in Abrdn life sciences stock - Investing.com India
Saba capital management sells $611,677 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
238,470 Shares in Abrdn Life Sciences Investors (NYSE:HQL) Bought by Raymond James Financial Inc. - MarketBeat
Aberdeen U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Saba Capital sells $474,961 in abrdn Life Sciences Investors stock By Investing.com - Investing.com Canada
Commonwealth Equity Services LLC Boosts Position in Abrdn Healthcare Investors (NYSE:HQH) - Defense World
Abrdn Healthcare Investors (NYSE:HQH) Shares Bought by HighTower Advisors LLC - Defense World
abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW) - Seeking Alpha
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.15%
1.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):